Novartis Trileptal
Executive Summary
Oxcarbazepine tablets are "approvable" Sept. 24 for the treatment of partial seizures. Trileptal will be indicated as monotherapy for first-line use in adults, Novartis said; the drug's indication in the pediatric population is still being worked out with FDA